Millie
your market intelligence analyst
Search Results
1,225 results
Your search is now limited to «Immunotherapy» expert search.
Traditional cancer treatments such as chemotherapy, radiation and immunotherapy have grown by leaps and bounds, but they each have their limitations.
More from Middle East North Africa Financial Network (MENAFN):
News-Medical.net 11/13/2019 18:10
In the past few years, these technologies have enabled the development of revolutionary engineered cell therapies for treating cancer, such as CAR-T cell cancer immunotherapies for leukemia and lymphoma.
More from News-Medical.net:
Business Wire 11/13/2019 16:30
NEW YORK--(BUSINESS WIRE)--Cellectis Publishes Creation of “Smart CAR T-Cells” for Potentially Safer, More Effective Treatments for Cancer in Nature Communications.
More from Business Wire:
PR Newswire 11/13/2019 15:30
Dragonfly Therapeutics Announces Celgene Opt-In of Third TriNKET™ Immunotherapy Drug Candidate.
More from PR Newswire:
Targeted Oncology 11/13/2019 13:37
Although many new treatments have emerged for patients with metastatic or advanced urothelial carcinoma, not all patients benefit from these advances.
More from Targeted Oncology:
BioNewsFeeds 11/13/2019 13:16
Immune checkpoint inhibitor therapies have transformed cancer treatment in certain solid malignant tumors, such as melanoma and renal cell carcinomas,” the researchers stated.
More from BioNewsFeeds:
FeedNavigator (EU) 11/13/2019 12:07
When the carcinoma is not that deep, that is, if it does not reach the alveolar canal, then there is no spread along the alveolar canal and little or no insinuation of the cancer cells beyond the tumor front [7 ...
More from FeedNavigator (EU):
Healio News 11/13/2019 11:26
We used nivolumab [Opdivo, Bristol-Myers Squibb] as our ICI backbone and tested whether its combination with sitravatinib would produce objective responses in immunotherapy-resistant urothelial carcinoma.
More from Healio News:
ClinicalTrials.gov 11/13/2019 10:14
Condition : Non Hodgkin Lymphoma Intervention : Drug: Kymriah Sponsors : University of Cologne; Novartis Not yet recruiting.
More from ClinicalTrials.gov:
Medindia.com 11/13/2019 09:10
Researchers not only suggest that heart disease and cancer risk may be linked, but also that doctors should be aware of heart disease as a side effect of cancer treatment.
More from Medindia.com:
ScienceDaily 11/13/2019 07:51
By comparing tissues from both patients with and without this more rare prostate cancer, the scientists found that it was BRN4 overexpression and interaction with another transcription factor in the same family, BRN2, driving the prostate cancer cells to become neuroendocrine prostate cancer cells.
More from ScienceDaily:
ESMO News (EU) 11/13/2019 03:40
Evolutionary divergence of HLA class I genotype impacts efficacy of cancer immunotherapy.
More from ESMO News (EU):
Cancer Network 11/13/2019
I think we’re all still waiting for that next big breakthrough, the next big leap forward, whether it is immune checkpoints or inflammatory agonists or other combinations for where immunotherapy will transform cancer treatment.
More from Cancer Network:
ENDPOINTS 11/12/2019 10:44
The new deal will expand the focus of their work to cover a subset of immune cells that have become an increasingly hot target for immunotherapy: gamma-delta cells.
More from ENDPOINTS:
Medical Xpress - Cancer News 11/12/2019 09:35
We can learn a lot from the amazing work being done and veterinary oncology can help a lot with that.
More from Medical Xpress - Cancer News:
GlobeNewswire 11/12/2019 09:01
Gritstone Oncology Reports Third Quarter 2019 Financial Results and Recent Highlights Nasdaq:GRTS.
More from GlobeNewswire:
Investing News Network 11/12/2019 07:52
About SABCS® Since its inception in 1977, San Antonio Breast Cancer Symposium (SABCS®) has grown to a five-day program that covers the latest research on the experimental biology, etiology, prevention, diagnosis, and treatment of breast cancer and premalignant breast disease.
More from Investing News Network:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications